Echocardiographic and magnetic resonance methods for diagnosing hibernating myocardium

Nuclear Medicine Communications

Volumn 23, Issue 4, 2002, Pages 331-339

  Cho, S ^a   McCONNELL, M V ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; Hibernating myocardium; MRI

Indexed keywords

CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGING; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING;

CARDIOTONIC AGENTS; CONTRAST MEDIA; CORONARY ARTERIOSCLEROSIS; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MYOCARDIAL STUNNING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036234235     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200204000-00006     Document Type: Article

References (51)

1. Chatterjee K, Swan HJC, Parmley WW et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patient with coronary heart disease with and without previous myocardial infarction. Circulation 1973; 47: 276-286.
2. Diamond GA, Forrester JS, deLuz PL, Wyatt AHL, Swan HJC. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978; 95: 204-209.
3. Elefteriades JA, Tolis G Jr, Levi E et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22: 1411-1417.
4. Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-795.
5. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina. Circulation 1985; 72(suppl V): V123-V135.
6. Tillisch J, Brunken R, Marshal R et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-888.
7. Bax JJ, Cornel JH, Visser FC et al. Prediction of recovery of myocardial dysfunction after revascularization: comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
8. Pasquet A, Robert A, D’Hondt A, Dion R, Melin JA, Vanoverschelde JLJ. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999; 100: 141-148.
9. Al-Mohammad, Mahy IR, Norton MY et al. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart 1998; 80: 559-564.
10. Schulz R, Heusch G. Hibernating myocardium. Heart 2000; 84: 587-594.
11. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998; 339(3): 173-181.
12. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart 1998; 80: 218-222.
13. Ferrari R, Ferrari F, Benigno M, Pepi P, Visioli O. Hibernating myocardium: its pathophysiology and clinical role. Mol Cell Biochem 1998; 186: 195-199.
14. Camici PG, Wijns W, Borgers M et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997; 96: 3205-3214.
15. Rahimtoola SH. Importance of diagnosing hibernating myocardium: how and in whom? J Am Coll Cardiol 1997; 30(7): 1701-1706.
16. Sawada S, Elsner G, Segar DS et al. Evaluation of patterns of perfusion and metabolism in dobutamine-responsive myocardium. J Am Coll Cardiol 1997; 29: 55-61.
17. Horn HR, Teichholz LE, Cohn PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation 1974; 49: 1063-1071.
18. Helfant RH, Pine R, Feldman MS, Trout RG, Banka VS. Nitroglycerine to unmask reversible asynergy: correlation with post coronary artery bypass ventriculography. Circulation 1974; 50: 108-113.
19. La Canna GL, Rahimtoola SH, Visioli O et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21: 1358-1367.
20. Cwajg JM, Cwajg E, Nagueh SF et al. Assessment of myocardial viability using 2D echo measurement of end-diastolic wall thickness: relation to Tl-201 uptake and comparative prediction of recovery of function. Circulation 1998; 98(suppl): 1-153.
21. Furukawa T, Haque T, Takahashi M, Kinoshita M. An assessment of dobutamine echocardiography and end-diastolic wall thickness for predicting post-revascularization functional recovery in patients with chronic coronary artery disease. Eur Heart J 1997; 18: 798-806.
22. Perrone-Filardi P, Bacharach SL, Dilsizian V et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischaemic left ventricular dysfunction. J Am Coll Cardiol 1992; 20: 161-168.
23. Hansen TH, Segar DS. The use of dobutamine stress echocardiography for the determination of myocardial viability. Clin Cardiol 1996; 19: 607-612.
24. Pierard LA, Hoffer EP. Role of stress echocardiography in heart failure. Am J Cardiol 1998; 81(12A): 111G-114G.
25. Afridi I, Kleiman NS, Raizner AE et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670.
26. Sawada S. Dobutamine echocardiography for detection of viable myocardium in ischemic cardiomyopathy. Echocardiography 2000; 27: 69-77.
27. Feigenbaum H. Coronary artery disease: detection of ischemic muscle. In: Feigenbaum H, eds. Echocardiography. Baltimore: Williams & Wilkins, 1994: 447-465.
28. Kornbluth M, Liang DH, Brown P, Gessford E, Schnittger I. Contrast echocardiography is superior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients. Am Heart J 2000; 140: 291-296.
29. Kornbluth M, Liang DH, Paloma A, Schnittger I. Native tissue harmonic imaging improves endocardial border definition and visualization of cardiac structures. J Am Soc Echocardiogr 1998; 11: 693-701.
30. Baer FM, Theissen P, Crnac J et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000; 21: 981-991.
31. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998; 79: 281-288.
32. Lu C, Carlino M, Fragasso G et al. Enoximone echocardiography for predicting recovery of left ventricular dysfunction after revascularization: a novel test for detecting myocardial viability. Circulation 2000; 101: 1255-1260.
33. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-1460.
34. Nagueh SF, Vaduganathan P, Ali N et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997; 29: 985-993.
35. Castro PF, Bourge RC, Foster RE. Evaluation of hibernating myocardium in patients with ischemic heart disease. Am J Med 1998; 104: 69-77.
36. de Fillipi CR, Willett DL, Irani WN et al. Comparison of myocardial contrast echocardiography and low dose of dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995; 92: 2863-2868.
37. Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001; 38: 19-25.
38. Meza MF, Ramee S, Collins T, Stapleton D, Milani RV, Murgo JP, Cheirif J. Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function postrevascularization: a study using the combination of myocardial contrast echocardiography and dobutamine echocardiography. Circulation 1997; 96: 3459-3465.
39. Higgins CB. Prediction of myocardial viability by MRI. Circulation 1999; 99: 727-729.
40. Baer FM, Theissen P, Schneider et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31(5): 1040-1048.
41. Sandstede JJW, Bertsch G, Beer M et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 1999; 17(10): 1437-1443.
42. Trent RJ, Waiter GD, Hillis GS, McKiddie FI, Redpath TW, Walton S. Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart 2000; 83: 40-46.
43. 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998; 98: 1869-1874.
44. Wilke N, Jerosch-Herold M. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first pass imaging. Cardiol Clin 1998; 16(2): 227-246.
45. Sandstede JJW, Lipke C, Beer M et al. Analysis of first-pass and delayed contrast enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. Am J Roentgenol 2000; 174: 1737-1743.
46. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
47. Rogers WJ, Kramer CM, Geskin G. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999; 99: 744-750.
48. Ramani K, Judd RM, Holly RA et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998; 98: 2687-2694.
49. Sensky PR, Jivan A, Hudson NM et al. Coronary artery disease: combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function. Radiology 2000; 215: 608-614.
50. 31P magnetic resonance spectroscopy. Circulation 1995; 92: 15-23.
51. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-718.